Sometimes we may choose to utilize a medicated eye drop called atropine in lieu of, or in addition to soft contact lenses or orthokeratology. Studies show that a low dose of atropine, typically administered as eye drops in the evening, has the potential to significantly slow the progression of myopia in children – helping prevent severe nearsightedness.
This treatment is not FDA approved; meaning we are using a medication to treat a condition other than its primary intended use. Because it is not FDA-approved, insurance does not cover this treatment.
The dosing is one drop into both eyes before bedtime. These eye drops may cause temporary stinging upon instillation, redness, and mild blur when looking at objects up close. By administering this treatment at night, these side effects are much less likely to affect your child during the day.